The European Commission said Germany’s Bayer had submitted commitments aimed at easing competition concerns over its US$66 billion takeover of US agrochemicals group Monsanto suggesting the company aims to avoid a lengthy review.
The Commission said it had extended a deadline by two weeks, aiming to complete its initial review of the deal by Aug. 22.
The German chemicals maker has previously agreed to major asset sales to win the go-ahead from competition authorities, though it did not comment on Tuesday on what it had offered to the European Commission.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Regulator Puts Brakes on £762 Million Logistics Merger Amid Competition Fears
Nov 3, 2024 by
CPI
Nvidia’s Acquisition of AI Startup Run.ai Faces EU Antitrust Review
Nov 3, 2024 by
CPI
Voters Across US to Decide on Landmark Gig Economy Issues on November Ballots
Nov 3, 2024 by
CPI
Court Gives Green Light to $110M Deal in Real Estate Commission Dispute
Nov 3, 2024 by
CPI
Mexico’s First-Ever Class Action Targets Pharma Giants for Price Fixing
Nov 3, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI